XML 205 R179.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Regulatory Capital Financial Instruments (Details) - Schedule of Regulatory Capital Financial Instruments - CLP ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Subordinated bonds [Member]    
Regulatory Capital Financial Instruments (Details) - Schedule of Regulatory Capital Financial Instruments [Line Items]    
Balance as of beginning $ 1,010,905 $ 917,510
Emissions made
Transaction costs
Transaction costs amortization
Accrued interest 34,903 31,271
Acquisition or redemption by the issuer
Modification of the issuance conditions
Interest and UF indexation payments to the holder (41,541) (42,866)
Principal payments to the holder (10,658) (15,184)
Accrued UF indexation 46,205 120,174
Exchange rate differences
Depreciation
Reappraisal
Expiration
Conversion to common shares
Balance as of ending 1,039,814 1,010,905
Bonds with no maturity [Member]    
Regulatory Capital Financial Instruments (Details) - Schedule of Regulatory Capital Financial Instruments [Line Items]    
Balance as of beginning
Emissions made
Transaction costs
Transaction costs amortization
Accrued interest
Acquisition or redemption by the issuer
Modification of the issuance conditions
Interest and UF indexation payments to the holder
Principal payments to the holder
Accrued UF indexation
Exchange rate differences
Depreciation
Reappraisal
Expiration
Conversion to common shares
Balance as of ending
Preferred shares [Member]    
Regulatory Capital Financial Instruments (Details) - Schedule of Regulatory Capital Financial Instruments [Line Items]    
Balance as of beginning
Emissions made
Transaction costs
Transaction costs amortization
Accrued interest
Acquisition or redemption by the issuer
Modification of the issuance conditions
Interest and UF indexation payments to the holder
Principal payments to the holder
Accrued UF indexation
Exchange rate differences
Depreciation
Reappraisal
Expiration
Conversion to common shares
Balance as of ending